Sofskin Vaporizing Chest Rub and Cough Suppressant

Description

The drug is identified by the SPL code 34089-3. It is associated with a principal display panel that provides essential labeling information. The effective time for the drug is noted as February 4, 2025. Additionally, an image of the label is referenced, indicating the presence of visual media related to the drug.

Uses and Indications

This drug is indicated for the temporary relief of nasal congestion, chest congestion, and cough associated with the common cold. Additionally, it provides temporary relief from minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the chest and throat to provide temporary relief from nasal congestion and coughing associated with colds, or to soothe sore, aching muscles. If preferred, the application may be loosely covered with a soft, dry cloth; however, it is important to ensure that clothing remains loose to avoid any restriction.

This application may be repeated up to three times daily, with particular emphasis on use at bedtime to enhance comfort during sleep.

For children under 2 years of age, it is essential to consult a physician prior to use to ensure safety and appropriateness of treatment.

Contraindications

There are no specified contraindications for this product. However, it is advised not to use the product near an open flame, in a microwave oven, or in a container where water is being heated, except when adding to cold water in a hot steam vaporizer. This precaution is necessary to prevent potential hazards associated with heat exposure.

Warnings and Precautions

The product is intended for external use only and must not be ingested. It is imperative to avoid contact with the eyes and to refrain from applying the product to the mouth, nostrils, or any wounds or damaged skin.

Healthcare professionals should advise patients to consult a physician prior to use if they have a history of asthma, emphysema, or a persistent or chronic cough. This includes coughs associated with smoking or excessive mucus production. Additionally, patients should seek medical advice if muscle aches persist for more than seven days, if the cough lasts longer than seven days, or if it recurs alongside symptoms such as fever, rash, or a persistent headache.

In the event of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

It is essential for healthcare providers to monitor patients for any adverse reactions and to ensure that they are aware of the appropriate steps to take in case of an emergency.

Side Effects

Patients should be aware that the product is intended for external use only and is not suitable for internal use. It is crucial to avoid contact with the eyes and to refrain from applying the product to the mouth, nostrils, or on wounds or damaged skin.

Before using the product, patients are advised to consult a physician if they have a history of asthma, emphysema, or a persistent or chronic cough, particularly if the cough is associated with smoking or excessive mucus production. Additionally, individuals should seek medical advice if muscle aches persist for more than 7 days, if they recur, or if a cough lasts more than 7 days, especially if accompanied by fever, rash, or a persistent headache.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Sofskin Vaporizing Chest Rub and Cough Suppressant (camphor, menthol, eucalyptus oil). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a physician before use. For children aged 2 years and older, a thick layer may be applied to the chest and throat to provide temporary relief from nasal congestion and coughing associated with colds, as well as to soothe sore, aching muscles.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a physician before using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a physician prior to using this medication. There is no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, healthcare professionals should consider the potential risks and benefits when recommending this medication to lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated, and consultation with a poison control center is recommended for guidance on management strategies tailored to the specific situation.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the medication near an open flame, in a microwave oven, or in a container where water is being heated, except when adding it to cold water in a hot steam vaporizer.

It is important for healthcare providers to recommend that patients consult a physician before using the medication if they have a history of asthma, emphysema, a persistent or chronic cough, a cough associated with smoking, or excessive mucus production. Additionally, patients should be instructed to seek medical advice if muscle aches persist for more than 7 days, if they recur, or if a cough lasts more than 7 days, returns, or occurs alongside fever, rash, or a persistent headache.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from excessive heat, and must not be frozen. After opening, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Sofskin Vaporizing Chest Rub and Cough Suppressant, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)